Insights & Resources
For Life Sciences Professionals.
Whether you’re a healthcare professional, a researcher, or simply interested in drug development, you’ll find valuable information and resources here that can help you stay informed and make informed decisions. Let us know what else you’d like to hear about!
Featured Insights
Case Study: International & Local Pharmacovigilance/Medical Information Services Urgent Action
Marketing Pharmaceutical Products in CIS/EAEU
Explore regulatory differences from the EU, recent legislative changes, and practical RA & PV considerations.
PV & MI Outsourcing Benefits for Biotech
Learn how PV/MI outsourcing enables biotechs to reduce costs, scale efficiently, strengthen compliance, and accelerate market readiness.
Topic
Role of the Local Person for Pharmacovigilance (LPPV)
The EU changes on the regulatory side have been significant. It has not only seen pharma companies face a new ...
Running Clinical Trials in Eastern Europe
It has become common practice for pharmaceutical companies to run clinical trials in Eastern Europe. However, it ...
All You Need To Know About Clinical Trials
So you want to improve your Clinical Trial expertise? Great! This field is snowballing and offers many ...
Selecting A CRO For An Early Phase Oncology Trial
As oncology drug developers, you likely know that selecting the proper Contract Research Organization (CRO) for ...
All You Need To Know About Pharmacovigilance
Pharmacovigilance is the process of monitoring the safety and effectiveness of medications. The term was ...
How Do Early Phase Oncology Trials Evolve?
In the last few years, a major breakthrough in cancer research has occurred: early phase oncology trials. This ...
Running A Clinical Trial In Georgia
Moving Clinical Trials away from Ukraine and Russia
Russia, Ukraine, and other CIS countries have been significant ...
Running A Clinical Trial In Kazakstan
Moving Clinical Trials away from Ukraine and Russia
For a long time, Russia, Ukraine and other countries in the ...
Artificial Intelligence in Pharmacovigilance
Automation & AI in Pharmacovigilance: Promises and Realistic Expectations
Recent years have seen increasing ...
How to Avoid Delays in Your Early Phase Oncology Trial?
Many things can go array in your early phase oncology trials, from protocol development, taking care of a safety ...
Pharmacovigilance Opportunities in the MENA Region
Pharmacovigilance is getting more and more attention in MENA countries thanks to new regulations and steps in the ...
Pharmacovigilance in the MENA Region
This blog focuses on pharmacovigilance (PV) in the MENA Region; the Middle East and North Africa. We do this by ...
Selecting a Pharmacovigilance Drug Safety Database
Selecting a Pharmacovigilance Drug Safety Database
The WHO defines pharmacovigilance (PV) as the science and ...
How does the conflict between UA & RU impact the pharma industry?
Like the rest of the world, the pharmaceutical and biotech industries are beginning to worry about their ability ...
How does the Russian invasion impact the pharmaceutical industry?
Like the rest of the world, the pharmaceutical and biotech industries are beginning to worry about their ability ...
How To Manage An Early Phase Oncology Study: Project Manager Insights
Clinical development of oncology drugs has one of the lowest success rates of the development of Investigational ...
How To Improve Patient Recruitment In Early Phase Oncology Trials
The difficulties of recruiting in clinical trials, and particularly cancer patients in their early stages, can ...
What are the advantages of a hospital-based Early Phase Unit?
Choosing the right setting for your early phase trial can be challenging. As a sponsor, it's natural to remain ...
Smooth Switch to the EAEU Marketing Authorization for Medicinal Products
Webinar: Smooth Switch to the EAEU Marketing Authorization for Medicinal Products
The webinar will highlight the ...
Finalization of the European Database on Medical Devices (Eudamed) Regulation Implementation
There is an increased demand for Materiovigilance solutions in recent years as the usage of medical devices keeps ...
